Filing Flows › Globus Medical (GMED) › Recalls, complaints & regulation
Globus Medical (GMED): recalls and clinical trials
Globus Medical (GMED) beyond its filings: 0 recalls in the last 12 months (6 in five years, 1 Class I); 2 active clinical trials.
Latest recalls
- 2025-04-30 · FDA device · MAGEC 2 Rod, 5.0mm 90mm Standard; Version/Model: MC2-5090S;
- 2024-02-14 · FDA device · ExcelsiusGPS Cannula A, 9mm x 250mm, Cannula used with ball tip probes, Model No. 6143.2844
- 2024-02-14 · FDA device · Globus Medical Cranial Drill, 6.00mm - instruments for access, preparation, and placement of cranial devices with the ExcelsiusGPS. Ref: 6143.1870S
- 2024-02-14 · FDA device · Globus Medical Cranial Drill with Stop, 2.40mm - Instruments for access, preparation, and placement of cranial devices with the ExcelsiusGPS. Ref : 6143.1834S
- 2024-02-14 · FDA device · Globus Medical Cranial Drill with Stop, 3.20mm - instruments for access, preparation, and placement of cranial devices with the ExcelsiusGPS. Ref: 6143.1842S
- 2024-01-24 · FDA device · ExcelsiusGPS Flat Panel Fluoroscopy Fixture Kit, Part number 6203.2100
Globus Medical's latest quarter
Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart follows the revenue to costs, profit and cash.
Questions
Has Globus Medical had any recalls?
6 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
How many clinical trials does Globus Medical have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.